PBA
SNDX icon

Paradigm Biocapital Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History

Paradigm Biocapital Advisors’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,390,077
Closed -$34.7M – 35
2023
Q3 		$34.7M Sell
2,390,077
-34,055
-1% -$644K 2.36% 17
2023
Q2 		$50.7M Buy
2,424,132
+149,620
+7% +$3.12M 3.92% 12
2023
Q1 		$48M Buy
2,274,512
+320,000
+16% +$7.96M 4.55% 10
2022
Q4 		$49.7M Buy
1,954,512
+869,370
+80% +$20.3M 5.84% 7
2022
Q3 		$26.1M Buy
1,085,142
+208,986
+24% +$4.69M 3.48% 14
2022
Q2 		$16.9M Buy
876,156
+174,800
+25% +$2.91M 3.36% 12
2022
Q1 		$12.2M Buy
701,356
+248,265
+55% +$4.18M 3.22% 14
2021
Q4 		$9.92M Buy
+453,091
New +$8.37M 2.83% 15

Other funds holding SNDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return